Bacterium-like particles derived from probiotics: progress, challenges and prospects.

Xinyao Zhou, Mingchun Gao, Xinqi De, Tong Sun, Zhikun Bai, Jilong Luo, Fang Wang, Junwei Ge

Journal: Frontiers in immunology 2023;14():1263586

PMID: 37868963

Abstract

Bacterium-like particles (BLPs) are hollow peptidoglycan particles obtained from food-grade inactivated by hot acid. With the advantage of easy preparation, high safety, great stability, high loading capacity, and high mucosal delivery efficiency, BLPs can load and display proteins on the surface with the help of protein anchor (PA), making BLPs a proper delivery system. Owning to these features, BLPs are widely used in the development of adjuvants, vaccine carriers, virus/antigens purification, and enzyme immobilization. This review has attempted to gather a full understanding of the technical composition, characteristics, applications. The mechanism by which BLPs induces superior adaptive immune responses is also discussed. Besides, this review tracked the latest developments in the field of BLPs, including -derived BLPs and novel anchors. Finally, the main limitations and proposed breakthrough points to further enhance the immunogenicity of BLPs vaccines were discussed, providing directions for future research. We hope that further developments in the field of antigen delivery of subunit vaccines or others will benefit from BLPs.

Copyright © 2023 Zhou, Gao, De, Sun, Bai, Luo, Wang and Ge.

Address: College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.; School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China.; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin, China.; Heilongjiang Provincial Key Laboratory of Zoonosis, Harbin, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.